Kestra Advisory Services
TGTX icon

Kestra Advisory Services’s TG Therapeutics TGTX Stock Holding History

Kestra Advisory Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$257K Buy
4,610
+631
+16% +$34.1K ﹤0.01% 3090
2026
Q2 		$219K Sell
3,979
-2,446
-38% -$100K ﹤0.01% 3045
2026
Q1 		$213K Sell
6,425
-2,043
-24% -$60.9K ﹤0.01% 2899
2025
Q4 		$252K Sell
8,468
-1,453
-15% -$47.5K ﹤0.01% 2686
2025
Q3 		$358K Sell
9,921
-1,854
-16% -$61.1K ﹤0.01% 2301
2025
Q2 		$424K Buy
11,775
+728
+7% +$27.1K ﹤0.01% 2086
2025
Q1 		$436K Sell
11,047
-1,896
-15% -$63.8K ﹤0.01% 1906
2024
Q4 		$390K Buy
12,943
+200
+2% +$5.74K ﹤0.01% 2044
2024
Q3 		$298K Sell
12,743
-615
-5% -$13.4K ﹤0.01% 2092
2024
Q2 		$238K Sell
13,358
-9,866
-42% -$157K ﹤0.01% 2285
2024
Q1 		$353K Sell
23,224
-537
-2% -$8.56K ﹤0.01% 1889
2023
Q4 		$406K Buy
23,761
+7,419
+45% +$86.2K ﹤0.01% 1649
2023
Q3 		$137K Buy
16,342
+1,240
+8% +$17.3K ﹤0.01% 1987
2023
Q2 		$375K Sell
15,102
-4,756
-24% -$123K ﹤0.01% 1475
2023
Q1 		$299K Buy
+19,858
New +$302K ﹤0.01% 1563

Other funds holding TGTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Penn Capital Management
Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Kestra Advisory Services's TGTX Position: Q3 2026 in Review

Kestra Advisory Services increased its TG Therapeutics (TGTX) stake by 16% in Q3 2026, buying an estimated $34.1K and bringing the position to 4,610 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #3090.

Kestra Advisory Services first reported a position in TGTX in Q1 2023 and has held it in 15 quarters since. The position peaked at $436K in Q1 2025. 208 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Kestra Advisory Services held 4,610 shares of TG Therapeutics worth $257K as of Q3 2026.
  • Kestra Advisory Services bought 631 TG Therapeutics shares in Q3 2026, an estimated $34.1K.
  • TG Therapeutics made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #3090 holding.
  • Kestra Advisory Services first reported a position in TG Therapeutics in Q1 2023 and has held it in 15 quarters since.
  • Kestra Advisory Services's TG Therapeutics position peaked at $436K in Q1 2025.
  • 208 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.